Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1][3]. Company Overview - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the United States and Canada [4]. Allegations and Stock Impact - The lawsuit claims that James Hardie misrepresented the strength and momentum of its North American fiber cement segment, attributing sales to sustainable customer demand rather than inventory loading by channel partners, which is indicative of fraudulent channel stuffing [5]. - On August 19, 2025, James Hardie disclosed a 12% decline in North American fiber cement sales, attributed to destocking efforts by customers, leading to a stock price drop of $9.79 per share, or over 34%, from $28.43 to $18.64 [6]. Legal Proceedings - Investors have until December 23, 2025, to request to lead the case in the U.S. District Court for the Northern District of Illinois, with the lawsuit captioned Laborers' District Council and Contractors' Pension Fund of Ohio v. James Hardie Industries plc, et al. [3].

Core Viewpoint - A class action lawsuit has been filed against Gauzy Ltd. for securities fraud, alleging that the company made misleading statements and failed to disclose material adverse facts about its financial condition and operations during the specified class period [1][5]. Summary by Sections Lawsuit Details - The lawsuit is filed in the United States District Court for the Southern District of New York, under the case name Duong v. Gauzy Ltd., and covers individuals and entities that purchased Gauzy securities between March 11, 2025, and November 13, 2025 [1][2]. - Investors have a 60-day window from the notice date to move the court to serve as lead plaintiff in the action [2][6]. Company Financial Issues - On November 14, 2025, Gauzy announced that the Commercial Court of Lyon, France, ordered insolvency proceedings for three of its subsidiaries, which could lead to a default under the company's senior secured debt facilities [3][5]. - The company will not release its third-quarter financial results as previously planned due to these proceedings [3]. Market Reaction - Following the announcement of the insolvency proceedings, Gauzy's share price dropped by $2.00, or 49.8%, closing at $2.02 per share on November 17, 2025, with unusually high trading volume [4]. Allegations in the Lawsuit - The complaint alleges that Gauzy's management made materially false and misleading statements and failed to disclose that three subsidiaries were unable to meet their debts, leading to the likelihood of insolvency proceedings and potential defaults on debt facilities [5].

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GAUZY LTD. (GAUZ), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@howardsmithlaw.com, by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com. What Happened? On November 14, 2025, before the market opened, Gauzy announced "the Commercial Court of Lyon, France, ordered the commencement of French ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Alexander & Baldwin, Inc. (NYSE: ALEX) to MW Group and funds affiliated with Blackstone Real Estate and DivcoWest for $21.20 per share in cash is fair to A&B shareholders. Halper Sadeh encourages A&B shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The inve ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Telix Pharmaceuticals Ltd. regarding a class action lawsuit due to alleged misleading statements made by the company during a specified period [1][3]. Group 1: Allegations - The complaint alleges that during the class period from February 21, 2025, to August 28, 2025, Telix Pharmaceuticals made materially false and misleading statements regarding its prostate cancer therapeutic candidates [3]. - It is claimed that the company overstated the progress made with its therapeutic candidates and the quality of its supply chain and partners [3]. - As a result of these misstatements, the company's statements about its business, operations, and prospects were deemed materially false and misleading [3]. Group 2: Class Action Details - Shareholders who purchased shares of TLX during the class period are encouraged to register for the class action, with a deadline set for January 9, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [4]. - There is no cost or obligation for shareholders to participate in this case [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that led to stock inflation [5].

Core Viewpoint - The lawsuit against Stride, Inc. alleges that the company misled investors regarding its operational health and compliance, leading to a significant stock crash of over 54% following damaging disclosures [1][4]. Summary by Relevant Sections Allegations - Stride is accused of inflating enrollment figures by retaining "ghost students" and failing to disclose operational and compliance failures, which artificially inflated its stock price [2][6]. - The company allegedly ignored compliance by increasing student-to-teacher ratios beyond required limits and neglecting mandated special education services [6]. Key Events - A public report on September 14, 2025, revealed a lawsuit by Gallup-McKinley school district alleging fraud, causing Stride's stock to drop by 11% [6]. - On October 28, 2025, Stride announced severe operational issues due to a failed platform upgrade, resulting in a stock crash of over 54% in one day [6]. Investor Information - Investors who purchased Stride securities between October 22, 2024, and October 28, 2025, and suffered losses may be eligible to serve as Lead Plaintiff in the class action lawsuit [5][6]. - The deadline for filing a motion for Lead Plaintiff is January 12, 2026 [6]. Whistleblower Information - Individuals with non-public information regarding Stride are encouraged to assist in the investigation or utilize the SEC Whistleblower program, which offers rewards up to 30% of any successful recovery [7].

Core Viewpoint - A class action lawsuit has been filed against DeFi Technologies Inc. for alleged securities fraud, seeking to recover losses for investors who purchased securities during the specified Class Period from May 12, 2025, to November 14, 2025 [1] Group 1: Lawsuit Details - The lawsuit aims to recover losses under federal securities laws for investors who acquired DeFi Technologies securities during the Class Period [1] - Investors have until January 30, 2026, to seek appointment as lead plaintiff if they suffered significant losses [2] Group 2: Allegations Against DeFi Technologies - The class action alleges that DeFi Technologies made false and misleading statements and failed to disclose material facts about its core business operations [3] - Specific undisclosed issues included delays in executing its DeFi arbitrage strategy, increased competition from other digital asset treasury companies, and an inability to meet previously issued fiscal year 2025 revenue guidance [6] - The company's public statements were deemed materially false and misleading throughout the Class Period due to the downplaying of the negative impacts on its business and financial results [6]

Core Viewpoint - The article discusses an investigation into WPP plc regarding potential violations of federal securities laws, specifically related to misleading statements about the company's expected revenue for fiscal year 2025 and the subsequent impact on its stock price [1][2]. Group 1: Allegations and Company Performance - The complaint alleges that WPP and its executives made false and misleading statements about the company's media division, claiming confidence in revitalization efforts while concealing the true challenges faced, including significant market share loss [2][3]. - WPP's trading update on July 9, 2025, indicated a deterioration in performance, attributing this to macroeconomic uncertainties and weaker new business, partly due to ongoing restructuring efforts [3][4]. Group 2: Stock Price Reaction - Following the negative trading update, WPP's stock price dropped from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, marking a decline of approximately 18.1% in one day [4]. Group 3: Legal Proceedings - The article outlines the process for investors to seek the role of lead plaintiff in the class action lawsuit, emphasizing that any member of the putative class can move the court to serve as lead plaintiff or remain an absent class member [5]. - The law firm Faruqi & Faruqi encourages individuals with information regarding WPP's conduct to come forward, including whistleblowers and former employees [6].

Core Viewpoint - A class action lawsuit has been filed against Blue Owl Capital Inc. for allegedly making materially false and misleading statements regarding its business and liquidity conditions during the specified Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Blue Owl Capital securities between February 6, 2025, and November 16, 2025 [1]. - Investors have until February 2, 2026, to seek appointment as lead plaintiff if they suffered losses during the Class Period [2]. - The complaint alleges that the defendants failed to disclose significant liquidity issues and redemption pressures, leading to substantial investor losses [3][6]. Group 2: Company Background - Blue Owl Capital is facing significant pressure on its asset base due to Business Development Company (BDC) redemptions, which has resulted in undisclosed liquidity issues [6]. - The company may need to limit or halt redemptions of certain BDCs due to these liquidity pressures, contradicting previous positive statements made by the defendants regarding the company's business and prospects [6]. Group 3: Law Firm Information - Johnson Fistel, PLLP is a recognized shareholder rights law firm that represents investors in securities class actions and has recovered approximately $90.7 million for investors in 2024 [4].

PHILADELPHIA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake” or the “Company”) on behalf of investors who purchased MoonLake shares during the period of March 10, 2024 through September 29, 2025 (the “Class Period”). Investor Deadline: Investors who purchased MoonLake securities during the Class Period may, no later than December 15, 2025, seek to be appointed as a lead plainti ...